Conference on drug discovery set for March 29

A daylong conference on drug discovery will bring together leaders and researchers in academia, industry and government.

The 2016 Stanford Drug Discovery Conference is scheduled from from 9 a.m. to 5:30 p.m. March 29 at the Li Ka Shing Center for Learning and Knowledge.

The conference is designed to bring together the collective experience of experts in drug discovery to discuss advances in research and technology. It will feature talks by leaders and researchers in academia, industry and government. Keynote speakers are Nobel laureate Brian Kobilka, MD, professor molecular and cellular physiology at Stanford; Christopher Austin, MD, director of the National Center for Advancing Translational Sciences; and Jessica Mega, MD, chief medical officer at Verily Life Sciences.

The event is free and open to the public. For more information or to register, visit the Stanford Cardiovascular Institute website



Stanford Medicine integrates research, medical education and health care at its three institutions - Stanford University School of Medicine, Stanford Health Care (formerly Stanford Hospital & Clinics), and Lucile Packard Children's Hospital Stanford. For more information, please visit the Office of Communication & Public Affairs site at http://mednews.stanford.edu.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.